The Impact of Nanoparticles on the Immune System: A Gray Zone of Nanomedicine

Priyanka Ray(North Dakota State University), Sushanta K. Banerjee(Kansas City VA Medical Center)

Journal of Immunological Sciences

February 1, 2021

10.29245/2578-3009/2021/1.1206

Cited by 136

Related Papers

Thombospondin-1 Disrupts Estrogen-Induced Endothelial Cell Proliferation and Migration and Its Expression Is Suppressed by Estradiol

|Molecular Cancer Research|2004|58

Deficiency of CCN5/WISP-2-Driven Program in breast cancer Promotes Cancer Epithelial cells to mesenchymal stem cells and Breast Cancer growth

|Scientific Reports|2017|31

CCN5 Activation by free or encapsulated-EGCG is required to Render Triple-negative breast cancer cell Viability and Tumor Progression

|Unknown|2022|20

pH-responsive targeted nanoparticles release ERK-inhibitor in the hypoxic zone and sensitize free gemcitabine in mutant K-Ras-addicted pancreatic cancer cells and mouse model

|PLoS ONE|2024|14

pH-responsive Targeted nanoparticles release ERK-inhibitor in the hypoxic zone Sensitizes Gemcitabine in Mutant K-Ras-addicted Pancreatic Cancer

|Research Square|2023|1